When Amanda Wlezen learned her cousin carried the cancer-causing BRCA2, she decided to go to OSF for genetic testing.

Trastuzumab emtansine is linked to a lower incidence of decrease in left ventricular ejection fraction than other trastuzumab containing regimens in ERBB2-positive advanced breast cancer, a ...